No Data
No Data
NeoGenomics (NASDAQ:NEO) Is Carrying A Fair Bit Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usu
Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer Month
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers' Mayor, Kevin Anderson, will be dedicating June as NeoG
Press Release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
PRESS RELEASE - 10/06/2024, 07:00 CEST Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing Mechelen, Belgium 10 June 2024 – Biocartis NV (the 'Company' or
Form 144 | NeoGenomics(NEO.US) Officer Proposes to Sell 198.34K in Common Stocks
SEC FILLINGS DISCLOSED/ May 28, $NeoGenomics(NEO.US)$ Officer BRUCE K CROWTHER intends to sell 13,882 shares of its common stock on May 28, with a total market value of approximately $198.34K. Sour
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS Hematopathology Services portfolio at the American Society of Clinical
NeoGenomics(NEO.US) Officer Sells US$16,511.26 in Common Stock
$NeoGenomics(NEO.US)$ Officer Olivo Alicia C sold 1,049 shares of common stock on May 15, 2024 at an average price of $15.74 for a total value of $16,511.26.Source: Announcement What is statement of c
No Data